Published:July 2011
No. of Pages: 36
Price: $515
Report Summary
Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available.
The Cooper Companies manufactures and markets speciality healthcare products through its CooperVision and CooperSurgical divisions.
CooperSurgical (CSI), based on Trumbull, Connecticut, US, manufactures and markets medical devices, diagnostic products and surgical instruments and accessories for women’s healthcare, which are primarily used by gynaecologists and obstetricians. The company has mainly developed through small acquisitions, purchasing over 30 businesses over the last 20 years. The most recent acquisition was in April 2011, when CSI acquired Apple Medical, a developer of obstetric and gynaecology products. CSI’s primary objective is to service the obstetricians and gynaecologists in the US, since the company believes this is a more US-centric profession. However, the company does have a presence in Europe.
CVI’s three largest competitors are Johnson & Johnson’s Vistakon division, CIBA Vision (owned by Novartis) and Bausch & Lomb. Together with CVI, these companies represent almost 95% of the global soft contact lens market.
CSI competes primarily with smaller technology-driven companies that generally offer only one or two product lines. However, the company is now expanding into the significantly larger hospital and out-patient surgical procedure market, which is dominated by larger competitors such as Johnson & Johnson’s Ethicon Endo-Surgery and Ethicon Women’s Health and Urology companies, Boston Scientific, Gyrus ACMI (an Olympus company) and Covidien.
For the financial year ended 31st October 2010 (fiscal 2010), The Cooper Companies reported net income of US$112.8 million on net sales of US$1,158.5 million. This represented increases of 12% and 7%, respectively, when compared with fiscal 2009. CVI generated 84% of The Cooper Companies’ revenue, while CSI accounted for the remaining 16% of net sales.
As of June 2011, The Cooper Companies had a total of approximately 7,100 employees.
This company report provides
Overview
Key contact information
Introduction to the company and its current activities
Summary of its financial performance
Who are the company’s major competitors?
Key recent events in an “at a glance” format
Financial Review
Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
Table providing in-depth five-year financial analysis
Employee data, including breakdown by company division and geographic location
Strategic Focus
Investigates the company’s aims and its areas of focus
Products
Core product areas, key brands, product approvals and launches Research and Development
How much has been invested in R&D?
Where is the research based?
What alliances and agreements does the company have and with whom?
Manufacturing and Distribution
Identifying the company’s manufacturing locations
Sales and marketing facilities
Agreements
With whom has the company reached agreements and what do they involve?
Key contracts awarded
Mergers, Acquisitions, Minority Investments and Divestments
Litigation
Key Corporate Events
The report was produced as part of Medical Device Companies Analysis (MDCA). For more information please click on the link to, Medical Device Companies Analysis.
Table Of Contents
OVERVIEW.1
FINANCIAL REVIEW 2
First Half Fiscal Year 2011 Financial Results.2
CVI.3
CSI.4
Fiscal Year 2010 Financial Results5
CVI.6
CSI.8
Five-Year Financial Data9
Outlook10
Employees.11
STRATEGIC FOCUS12
PRODUCTS13
CVI13
CSI.16
RESEARCH AND DEVELOPMENT.22
MANUFACTURING AND DISTRIBUTION23
Manufacturing.23
Distribution.23
AGREEMENTS 24
CIBA Vision.24
Gebauer Medizintechnik24
Advanced Medical Optics.25
Rohto Pharmaceutical Company.25
Eyefinity.25
Welch Allyn25
MERGERS AND ACQUISITIONS 26
Apple Medical27
Asahikasei Aime Assets.27
American Medical Systems Assets.27
JLJ Medical Devices International27
Intuitive Surgical's Uterine Positioning System27
Wallach Surgical Devices28
Lone Star Medical Products28
NeoSurg Technologies/Inlet Medical28
Ocular Sciences28
Opti-Centre29
Milex Products.29
Argus Biomedical’s AlphaCor and AlphaSphere Products.29
SURx’ Radiofrequency Bladder Neck Suspension Technology29
Avalon Medical30
Prism Enterprises.30
SAGE BioPharma30
Ackrad Laboratories30
Orthometrix/Norland Medical Systems’ Bone Densitometry Business31
Biocompatibles Eye Care31
Medscand Medical.31
CL-Tinters Oy32
MedAmicus’ LuMax Fiber Optic Cystometry System32
MedaSonics32
Leisegang Medical’s Women’s Healthcare Products.32
BEI Medical Systems’ Women’s Healthcare Products.32
Aspect Vision Care Ltd.33
Marlow Surgical Technologies.33
Unimar33
RUMI Uterine Manipulator.33
MINORITY INVESTMENTS.34
Quidel.34
DIVESTITURES 35
CooperVision Surgical.35
Quidel.35
Hospital Group of America.35
LITIGATION.36
Rembrandt Vision Technologies .36
Internal Revenue Service36
Securities Litigation36
KEY CORPORATE EVENTS37
List of Tables
SUMMARY OPERATING RESULTS.iii
Recent Key Events1
The Cooper Companies – First Half Fiscal 2011 Financial Results.2
The Cooper Companies – First Half Fiscal 2011 Net Sales by Geographic Region.2
CVI – Selected First Half Fiscal 2011 Financial Results3
CVI – First Half Fiscal 2011 Revenues By Key Product.3
CVI – First Half Fiscal 2011 Sales by Geographic Area.3
CSI – Selected First Half Fiscal 2011 Financial Results.4
The Cooper Companies – Annual Financial Results, Fiscal Years 2006-2010.5
The Cooper Companies – Annual Net Sales by Geographic Region, Fiscal Years 2006-2010 5
CVI – Selected Annual Financial Results, Fiscal Years 2008-20106
CVI – Annual Revenues By Key Product, Fiscal Years 2008-2010.7
CVI – Annual Revenues by Geographic Region, Fiscal Years 2008-20107
CSI – Selected Annual Financial Results, Fiscal Years 2008-2010.8
The Cooper Companies – Five-Year Financial Summary, Fiscal Years 2006-2010.9
Soft Contact Lens Market by Region and by Competitor, Q1 201114
Global Soft Lens Market – Modality Breakdown by Region, Q1 201114
Global Soft Contact Lens Market – Estimated Five-Year Sales Trend by Product, Calendar Year 2010-2015 15
Global Soft Contact Lens Market – Estimated Five-Year Sales Trend by Region, Calendar Year 2010-2015 15
CVI – Key Contact Lens Brands, July 2011.15
CSI Market Shares, Fiscal Year 200918
CooperSurgical – Key Products, July 201119
Cooper Companies – Annual R&D Expenditure, Fiscal Years 2008-2010.22
Agreements Summary24
Mergers and Acquisitions Summary.26
List of Charts
The Cooper Companies - Annual Net Sales and Operating Income, Fiscal Years 2006-2010 5
The Cooper Companies - Annual Net Sales by Geographic Region, Fiscal Years 2006-2010.6
CVI - Annual Sales and Operating Income, Fiscal Years 2008-2010.6
CVI - Annual Net Sales by Geographic Area, Fiscal Years 2008-20107
CSI - Annual Net Sales and Operating Income, Fiscal Years 2008-2010.8
Global Soft Contact Lens Market by Competitor, Q1 2011.14
CSI – Office-based Sales by Product Type, Fiscal 201016
CSI – Hospital Sales by Medical Procedure/Segment, Fiscal 201017
CSI – Fertility Clinic Sales by Product Type, Fiscal 2010.17
No. of Pages: 36
Price: $515
Report Summary
Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available.
The Cooper Companies manufactures and markets speciality healthcare products through its CooperVision and CooperSurgical divisions.
CooperVision (CVI), headquartered in Pleasanton, California, US, manufactures and markets a broad range of contact lenses and, following its acquisition of Ocular Sciences in 2005, became one of the most successful players in this market. CVI’s primary offices are in the US and the UK and its manufacturing facilities are located in the US, the UK and Puerto Rico. Its principal medical device markets are the US, Europe and the Asia-Pacific region.
CooperSurgical (CSI), based on Trumbull, Connecticut, US, manufactures and markets medical devices, diagnostic products and surgical instruments and accessories for women’s healthcare, which are primarily used by gynaecologists and obstetricians. The company has mainly developed through small acquisitions, purchasing over 30 businesses over the last 20 years. The most recent acquisition was in April 2011, when CSI acquired Apple Medical, a developer of obstetric and gynaecology products. CSI’s primary objective is to service the obstetricians and gynaecologists in the US, since the company believes this is a more US-centric profession. However, the company does have a presence in Europe.
CVI’s three largest competitors are Johnson & Johnson’s Vistakon division, CIBA Vision (owned by Novartis) and Bausch & Lomb. Together with CVI, these companies represent almost 95% of the global soft contact lens market.
CSI competes primarily with smaller technology-driven companies that generally offer only one or two product lines. However, the company is now expanding into the significantly larger hospital and out-patient surgical procedure market, which is dominated by larger competitors such as Johnson & Johnson’s Ethicon Endo-Surgery and Ethicon Women’s Health and Urology companies, Boston Scientific, Gyrus ACMI (an Olympus company) and Covidien.
For the financial year ended 31st October 2010 (fiscal 2010), The Cooper Companies reported net income of US$112.8 million on net sales of US$1,158.5 million. This represented increases of 12% and 7%, respectively, when compared with fiscal 2009. CVI generated 84% of The Cooper Companies’ revenue, while CSI accounted for the remaining 16% of net sales.
As of June 2011, The Cooper Companies had a total of approximately 7,100 employees.
This company report provides
Overview
Key contact information
Introduction to the company and its current activities
Summary of its financial performance
Who are the company’s major competitors?
Key recent events in an “at a glance” format
Financial Review
Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
Table providing in-depth five-year financial analysis
Employee data, including breakdown by company division and geographic location
Strategic Focus
Investigates the company’s aims and its areas of focus
Products
Core product areas, key brands, product approvals and launches Research and Development
How much has been invested in R&D?
Where is the research based?
What alliances and agreements does the company have and with whom?
Manufacturing and Distribution
Identifying the company’s manufacturing locations
Sales and marketing facilities
Agreements
With whom has the company reached agreements and what do they involve?
Key contracts awarded
Mergers, Acquisitions, Minority Investments and Divestments
Litigation
Key Corporate Events
The report was produced as part of Medical Device Companies Analysis (MDCA). For more information please click on the link to, Medical Device Companies Analysis.
Table Of Contents
OVERVIEW.1
FINANCIAL REVIEW 2
First Half Fiscal Year 2011 Financial Results.2
CVI.3
CSI.4
Fiscal Year 2010 Financial Results5
CVI.6
CSI.8
Five-Year Financial Data9
Outlook10
Employees.11
STRATEGIC FOCUS12
PRODUCTS13
CVI13
CSI.16
RESEARCH AND DEVELOPMENT.22
MANUFACTURING AND DISTRIBUTION23
Manufacturing.23
Distribution.23
AGREEMENTS 24
CIBA Vision.24
Gebauer Medizintechnik24
Advanced Medical Optics.25
Rohto Pharmaceutical Company.25
Eyefinity.25
Welch Allyn25
MERGERS AND ACQUISITIONS 26
Apple Medical27
Asahikasei Aime Assets.27
American Medical Systems Assets.27
JLJ Medical Devices International27
Intuitive Surgical's Uterine Positioning System27
Wallach Surgical Devices28
Lone Star Medical Products28
NeoSurg Technologies/Inlet Medical28
Ocular Sciences28
Opti-Centre29
Milex Products.29
Argus Biomedical’s AlphaCor and AlphaSphere Products.29
SURx’ Radiofrequency Bladder Neck Suspension Technology29
Avalon Medical30
Prism Enterprises.30
SAGE BioPharma30
Ackrad Laboratories30
Orthometrix/Norland Medical Systems’ Bone Densitometry Business31
Biocompatibles Eye Care31
Medscand Medical.31
CL-Tinters Oy32
MedAmicus’ LuMax Fiber Optic Cystometry System32
MedaSonics32
Leisegang Medical’s Women’s Healthcare Products.32
BEI Medical Systems’ Women’s Healthcare Products.32
Aspect Vision Care Ltd.33
Marlow Surgical Technologies.33
Unimar33
RUMI Uterine Manipulator.33
MINORITY INVESTMENTS.34
Quidel.34
DIVESTITURES 35
CooperVision Surgical.35
Quidel.35
Hospital Group of America.35
LITIGATION.36
Rembrandt Vision Technologies .36
Internal Revenue Service36
Securities Litigation36
KEY CORPORATE EVENTS37
List of Tables
SUMMARY OPERATING RESULTS.iii
Recent Key Events1
The Cooper Companies – First Half Fiscal 2011 Financial Results.2
The Cooper Companies – First Half Fiscal 2011 Net Sales by Geographic Region.2
CVI – Selected First Half Fiscal 2011 Financial Results3
CVI – First Half Fiscal 2011 Revenues By Key Product.3
CVI – First Half Fiscal 2011 Sales by Geographic Area.3
CSI – Selected First Half Fiscal 2011 Financial Results.4
The Cooper Companies – Annual Financial Results, Fiscal Years 2006-2010.5
The Cooper Companies – Annual Net Sales by Geographic Region, Fiscal Years 2006-2010 5
CVI – Selected Annual Financial Results, Fiscal Years 2008-20106
CVI – Annual Revenues By Key Product, Fiscal Years 2008-2010.7
CVI – Annual Revenues by Geographic Region, Fiscal Years 2008-20107
CSI – Selected Annual Financial Results, Fiscal Years 2008-2010.8
The Cooper Companies – Five-Year Financial Summary, Fiscal Years 2006-2010.9
Soft Contact Lens Market by Region and by Competitor, Q1 201114
Global Soft Lens Market – Modality Breakdown by Region, Q1 201114
Global Soft Contact Lens Market – Estimated Five-Year Sales Trend by Product, Calendar Year 2010-2015 15
Global Soft Contact Lens Market – Estimated Five-Year Sales Trend by Region, Calendar Year 2010-2015 15
CVI – Key Contact Lens Brands, July 2011.15
CSI Market Shares, Fiscal Year 200918
CooperSurgical – Key Products, July 201119
Cooper Companies – Annual R&D Expenditure, Fiscal Years 2008-2010.22
Agreements Summary24
Mergers and Acquisitions Summary.26
List of Charts
The Cooper Companies - Annual Net Sales and Operating Income, Fiscal Years 2006-2010 5
The Cooper Companies - Annual Net Sales by Geographic Region, Fiscal Years 2006-2010.6
CVI - Annual Sales and Operating Income, Fiscal Years 2008-2010.6
CVI - Annual Net Sales by Geographic Area, Fiscal Years 2008-20107
CSI - Annual Net Sales and Operating Income, Fiscal Years 2008-2010.8
Global Soft Contact Lens Market by Competitor, Q1 2011.14
CSI – Office-based Sales by Product Type, Fiscal 201016
CSI – Hospital Sales by Medical Procedure/Segment, Fiscal 201017
CSI – Fertility Clinic Sales by Product Type, Fiscal 2010.17
No comments:
Post a Comment